Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 11;14(4):894.
doi: 10.3390/genes14040894.

Molecular and Sociodemographic Colorectal Cancer Disparities in Latinos Living in Puerto Rico

Affiliations

Molecular and Sociodemographic Colorectal Cancer Disparities in Latinos Living in Puerto Rico

Julyann Perez-Mayoral et al. Genes (Basel). .

Abstract

Background: The incidence of sporadic colorectal cancer (CRC) among individuals <50 years (early-onset CRC) has been increasing in the United States (U.S.) and Puerto Rico. CRC is currently the leading cause of cancer death among Hispanic men and women living in Puerto Rico (PRH). The objective of this study was to characterize the molecular markers and clinicopathologic features of colorectal tumors from PRH to better understand the molecular pathways leading to CRC in this Hispanic subpopulation.

Methods: Microsatellite instability (MSI), CpG island methylator phenotype (CIMP), and KRAS and BRAF mutation status were analyzed. Sociodemographic and clinicopathological characteristics were evaluated using Chi-squared and Fisher's exact tests.

Results: Of the 718 tumors analyzed, 34.2% (n = 245) were early-onset CRC, and 51.7% were males. Among the tumors with molecular data available (n = 192), 3.2% had MSI, 9.7% had BRAF, and 31.9% had KRAS mutations. The most common KRAS mutations observed were G12D (26.6%) and G13D (20.0%); G12C was present in 4.4% of tumors. A higher percentage of Amerindian admixture was significantly associated with early-onset CRC.

Conclusions: The differences observed in the prevalence of the molecular markers among PRH tumors compared to other racial/ethnic groups suggest a distinct molecular carcinogenic pathway among Hispanics. Additional studies are warranted.

Keywords: Hispanics; colorectal cancer; early-onset colorectal cancer; molecular markers.

PubMed Disclaimer

Conflict of interest statement

MCC reports research support from the following pharmaceutical companies: Abbvie, BMS, Regeneron, QED, SeaGen, Janssen, TAIHO, BeiGene, MIRATI, Merck, Gilead, Pfizer, Natera, Genentech, Elli Lilly, and Apollomics. The content of this manuscript is not related to the research support from the pharmaceutical industry.

References

    1. Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer statistics. CA Cancer J. Clin. 2022;72:7–33. doi: 10.3322/caac.21708. - DOI - PubMed
    1. Gonzalez-Pons M., Torres M., Perez J., Velez A., Betancourt J.P., Marcano L., Soto-Salgado M., Cruz-Correa M. Colorectal Cancer Survival Disparities among Puerto Rican Hispanics: A Comparison to Racial/Ethnic Groups in the United States. Cancer Clin. Oncol. 2016;5:29–37. doi: 10.5539/cco.v5n2p29. - DOI - PMC - PubMed
    1. Zavala V.A., Bracci P.M., Carethers J.M., Carvajal-Carmona L., Coggins N.B., Cruz-Correa M.R., Davis M., de Smith A.J., Dutil J., Figueiredo J.C., et al. Cancer health disparities in racial/ethnic minorities in the United States. Br. J. Cancer. 2020;124:315–332. doi: 10.1038/s41416-020-01038-6. - DOI - PMC - PubMed
    1. Siegel R.L., Miller K.D., Sauer A.G., Fedewa S.A., Butterly L.F., Anderson J.C., Cercek A., Smith R.A., Jemal A. Colorectal cancer statistics. CA Cancer J. Clin. 2020;70:145–164. doi: 10.3322/caac.21601. - DOI - PubMed
    1. Pinheiro P.S., Callahan K.E., Siegel R.L., Jin H., Morris C.R., Trapido E.J., Gomez S.L. Cancer Mortality in Hispanic Ethnic Groups. Cancer Epidemiol. Biomark. Prev. 2017;26:376–382. doi: 10.1158/1055-9965.EPI-16-0684. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances